Updated Date: Wed, 26 Jun 2024 00:00:00 EDT
The progressive neurological condition affects around 153,000 people in the UK
Updated Date: Wed, 26 Jun 2024 00:00:00 EDT
Updated Date: Wed, 26 Jun 2024 00:00:00 EDT
Updated Date: Wed, 26 Jun 2024 00:00:00 EDT
Research could help drug developers improve the safety profiles of medications and reduce side effects.
US Supreme Court strikes down Sackler family’s immunity, casting Purdue opioid settlement into doubt
A $9bn legal settlement agreed between Purdue Pharma, the drug company whose misleading marketing helped to trigger the […]
Dementias, including Alzheimer’s disease, are estimated to affect 944,000 people in the UK
Chronic migraine is a neurological condition estimated to affect up to 2.2% of people globally
